Group 1 - The company has signed a sales agreement with Changcheng Securities to sell its medical industry equity fund starting from August 18, 2025 [1] - The fund is available for subscription and redemption only during specific open periods, as detailed in the fund's legal documents [1][2] - Investors can inquire about details through the company's customer service or the sales institution's website [3][4] Group 2 - The company warns investors about the premium risk associated with its Nasdaq Technology Index ETF, which is trading significantly above its net asset value [6] - The ETF will be suspended from trading on August 18, 2025, until 10:30 AM to protect investors from potential losses due to high premiums [6] - The fund management assures that it will operate according to legal regulations and fulfill its disclosure obligations [7]